Can Nel ASA scale to gigawatt electrolyzers and reignite its next phase of growth?
Nel ASA's pivot to industrial-scale electrolyzers merits attention after 2025 impairment hits; management targets gigawatt projects and cost cuts, with 2025 revenue down and heavy write-downs signaling a make-or-break 2026 recovery. NEL SWOT Analysis

Navigating capex discipline and production ramp is critical; focus on supply contracts and stack cost reduction will determine if Nel converts pilots into profitable gigawatts.
Where Is NEL Trying to Go Next?
Nel ASA is concentrating on high-capacity industrial decarbonization via large-scale hydrogen electrolyzers, targeting North America and Europe with a 4 GW build plan and a shift from fueling-station sales to multi-megawatt project contracts.
Nel ASA's primary growth is selling multi-megawatt alkaline and PEM electrolyzers into industrial decarbonization projects; large buyers favor proven, high-capacity suppliers and Nel targets a 4 GW pipeline to capture volume-driven margin expansion.
North America (leveraging the US 45V production tax credit) and EU (targeting Hydrogen Bank auctions) are the two hubs; winning project awards in both regions secures long-term revenues and order backlog.
Beyond units, Nel can expand into plant-level EPC, long-term service contracts, and stack-to-plant integrations to lift recurring revenue and improve lifetime margins per project.
The most realistic 2025-2026 outcome is ramping production capacity and securing 4 GW of awarded projects split between PEM and alkaline to exploit tax credits and EU auction awards; this directly supports the path to EBITDA break even by early 2026.
Nel ASA is prioritizing large electrolyzer supply to industrial clients in North America and Europe, focusing on a 4 GW commercial buildout, capturing incentives like the 45V PTC in the US and EU Hydrogen Bank auctions to convert backlog into high-margin, multi-megawatt contracts.
- Primary growth opportunity: scale multi-megawatt electrolyzer sales to industrial decarbonization projects
- Expansion potential: secure awards in North America and EU auctions to build an enduring project pipeline
- Product/category upside: add EPC, long-term O&M, and system integration to raise recurring revenue
- Most credible near-term driver: converting bids into awarded contracts to hit EBITDA break even by early 2026 and target 20% EBITDA margins by 2028
Relevant reading: Who NEL Company Serves
NEL SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Is NEL Building to Get There?
Nel ASA is building a scaled, lower-cost electrolyzer platform, a US supply chain, and modular, containerized products to capture green-hydrogen demand. Key actions: commercialize the Next Generation Pressurized Alkaline at 1 GW capacity, invest about $400,000,000 in Michigan, and push modular MC 500 units plus large EPC partnerships.
Nel is prioritizing scale in Norway and the United States to serve Europe and North America, while targeting project wins in Asia via partners. The firm aims to broaden channels by supplying electrolyzers into large EPC projects and industrial offtake contracts.
The Next Generation Pressurized Alkaline platform promises 40-60% lower system CAPEX and an 80% smaller installation footprint; commercial launch is set for May 6, 2026. Modular MC 500 containerized systems simplify logistics and accelerate project delivery.
Nel focuses on modular hardware (MC 500) and factory standardization to cut installation time and costs; digital monitoring and production automation support scale. These tech moves reduce balance-of-plant risk and speed commissioning.
Nel is partnering with General Motors, Reliance, Samsung E&A, and Saipem to embed electrolyzers within large energy and industrial projects. These alliances target turnkey delivery and market access across key geographies.
Following an FID to scale Next Generation Pressurized Alkaline to 1 GW at Herøya, Nel is allocating roughly $400,000,000 to its US Michigan site to establish a domestic supply chain. Rollout timeline centers on 2025-2026 commercial ramp and delivery cadence into 2027.
The Herøya 1 GW build tied to the Next Generation Pressurized Alkaline platform is the single most important move in 2025/2026 because it underpins targeted 40-60% CAPEX reductions and global competitiveness in electrolyzer pricing.
Nel ASA is scaling manufacturing, slashing system CAPEX, and localizing supply chains to win large green-hydrogen projects worldwide; modular MC 500 units and EPC partnerships convert product improvements into deployable systems.
- Scale priority: ramp 1 GW Next Generation Pressurized Alkaline at Herøya
- Key innovation: pressure alkaline platform reducing CAPEX by 40-60%
- Top partnership: integrations with General Motors, Reliance, Samsung E&A, and Saipem to access EPC pipelines
- 2025/2026 strategic action: $400,000,000 Michigan investment to create a US supply chain and shorten delivery lead times
For context on competitive positioning and market peers, see Who NEL Company Competes With
NEL PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What Could Slow NEL Down?
Nel ASA faces slower orders, financing headwinds, and subsidy uncertainty that can stall projects and revenue. High interest rates, a widening FID (final investment decision) gap, and impairments amplify execution risk and cash volatility.
Project announcements are not translating into orders as customers delay final investment decisions amid financing strain; 2025 revenue fell 31 percent to 963 million NOK, reflecting softer demand for electrolyzers.
Regionalization pushes manufacturers to localize production, increasing overhead and intensifying price competition; customers may switch to cheaper or nearer suppliers, compressing margins.
Capital-intensive expansions, like the planned Michigan facility, depend on stable subsidies and financing; Nel took a 799 million NOK impairment in late 2025 on alkaline assets and PEM goodwill, signaling vulnerability to large non-cash charges.
Rollback or delay of US 45V tax credits or changes to EU subsidy frameworks would directly threaten the Michigan build and the European backlog; supply-chain pressures and macro volatility add further risk.
Nel ASA future growth hinges on converting project pipeline into firm orders, securing subsidies and financing, and avoiding further impairments; failure on any front could sharply reduce revenue and delay NEL hydrogen strategy milestones.
- Delayed FIDs and weaker order intake reduced revenue to 963 million NOK in 2025
- High capex and execution risk for Michigan expansion and European scaling
- Policy shifts-US 45V tax credit or EU subsidy rollbacks-would undercut project economics
- The single biggest risk: inability to convert backlog into funded orders, triggering further impairments and cash stress
For context on strategy and positioning, see What NEL Company Stands For
NEL SOAR Analysis
- Complete SOAR Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
How Strong Does NEL's Growth Story Look?
NEL ASA's growth story is mixed but showing early signs of a turning point; commercial momentum is strong while profitability remains fragile. The company looks positioned for uneven progress hinging on 2026 execution and technology delivery.
Outlook: mixed-to-improving. Order intake and backlog point to accelerating revenue potential, but a widened 2025 net loss of 1.27 billion NOK leaves earnings vulnerable.
Q4 2025 order intake jumped 364 percent to 686 million NOK, led by a record 40 MW PEM order worth over 50 million USD from HYDS; backlog stands at 1.319 billion NOK.
Capital runway is solid with a cash balance of 1.617 billion NOK, enabling the May 2026 launch and conversion of FEED (front-end engineering design) pipeline into firm orders if industrial execution holds.
If the pressurized alkaline platform delivers promised levelized cost of hydrogen (LCOH) cuts, NEL ASA future performance could accelerate materially via larger project wins and faster market expansion.
Main risk: technology or execution shortfalls-if the pressurized alkaline gains underdeliver or FEED conversions stall, cash burn and margin pressure will keep the story fragile.
Judgment: cautiously optimistic. Growth depends on industrial execution, conversion of the FEED pipeline, and validating the electrolyzer efficiency gains in 2026.
Nonsense removed: the clearest conclusion is that NEL ASA shows strong commercial momentum but remains earnings-fragile; 2026 is binary-success hinges on technology performance and FEED-to-order conversion.
- NEL ASA future: positioned for moderate-to-strong growth if 2026 execution and tech gains validate LCOH reductions.
- Most supportive near-term signal: Q4 2025 order intake up 364 percent to 686 million NOK and a 1.319 billion NOK backlog.
- Biggest upside: pressurized alkaline electrolyzer delivering lower LCOH and triggering larger projects, boosting NEL hydrogen strategy and market expansion.
- Main downside risk: failed tech delivery or slow FEED pipeline conversion leading to continued net losses and constrained growth.
For context on sales and commercial approach, see How NEL Company Sells
NEL VRIO Analysis
- Covers VRIO Analysis in Details
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
Frequently Asked Questions
NEL is trying to grow through high-capacity industrial hydrogen electrolyzers. The blog says it is shifting from fueling-station sales toward multi-megawatt project contracts, with a focus on North America and Europe and a 4 GW commercial build plan.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.